Twin Health, a metabolic health technology company, has raised $53 million in new funding led by Denmark’s Maj Invest. This fresh investment aims to propel the company’s growth into Fortune 500 enterprises and health plans across diverse sectors, including retail, healthcare, finance, technology, and manufacturing.
At the heart of Twin Health’s approach is its real-time AI digital twin platform, a breakthrough technology that creates personalized metabolic models for individuals using data from biomarkers, habits, and preferences. Unlike conventional metabolic programs that often resort to medications and restrictive diets, Twin’s system combines advanced AI with compassionate human support teams.
Members benefit from daily, tailored guidance and live coaching, which helps them lower A1C levels, achieve weight goals, and, in many cases, safely transition off medications such as GLP-1s.
Twin Health stands out by offering performance-based care: employers and health plans only pay when members achieve significant clinical results, such as improved A1C levels, weight loss, or reduced medication use. If milestones aren’t met, no payment is required. This results-driven model has enabled Twin to achieve a high client retention rate and exceptional industry conversion metrics.
As the use of GLP-1 medications continues to rise, Twin Health empowers organizations to implement responsible, evidence-based strategies. Their platform identifies eligible individuals, supports appropriate medication use when needed, and provides personalized paths to reduce or eliminate long-term dependence on costly drugs.
Backed by newly published, peer-reviewed studies showing significant outcomes for diabetes and weight management, Twin Health is setting a new benchmark for metabolic care—blending cutting-edge technology with ongoing, individualized human support for lasting health transformation.
KEY QUOTES:
“Diabetes and obesity are among the world’s biggest health challenges. For decades, we have invested in cutting-edge solutions to address the epidemic of metabolic disease. Twin Health represents a paradigm shift in diabetes and obesity care – one that is precise to each individual and scalable for employers and health plans.”
Jeppe Christianson, CEO of Maj Invest
“Traditional solutions have focused on just managing the disease. Twin is different. We address the root causes of chronic metabolic diseases to improve and reverse diabetes. Members use their own biomarker data—not population averages — to create their own AI digital twin that guides them in a way that is engaging, precise, and sustainable. We believe metabolic health is a continuous condition, not an episodic event, and Twin delivers continuous, 24/7 guidance to meet that reality. We envision a future where everyone has an AI digital twin to improve their health and reduce healthcare spend.”
Jahangir Mohammed, founder and CEO of Twin Health
